IP Library Granted Patent US 7,006,871
Granted Patent B1
US 7,006,871 · App. 09/914,889 · Granted Feb 28, 2006

Blood glucose level control

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,006,871
App. No.
09/914,889
Granted
Feb 28, 2006
Kind
B1
Abstract

A pancreatic controller ( 102 ), comprising: a glucose sensor ( 118 ), for sensing a level of glucose or insulin in a body serum; at least one electrode ( 110, 112 ), for electrifying an insulin producing cell or group of cells; a power source ( 104 ) for electrifying said electrode with a pulse that does not initiate an action potential in said cell and has an effect of increasing insulin secretion; and a controller ( 106 ) which receives the sensed level and controls said power source to electrify said electrode to have a desired effect on said level.

Claims (57)

1. A pancreatic controller, comprising:

a glucose sensor, for sensing a level of glucose or insulin in a body serum;

at least one electrode, for electrifying an insulin producing cell or group of cells;

a power source for electing said at least one electrode with a pulse that does not initiate an action potential in said cell and has an effect of increasing insulin secretion; and

a controller which receives the sensed level and controls said power source to electrify said at least one electrode to have a desired effect on said level.

2. Apparatus according to claim 1 , wherein said insulin producing cell is contiguous with a pancreas and wherein said electrode is adapted for being placed adjacent said pancreas.

3. Apparatus according to claim 1 , wherein said controller comprises a casing suitable for long term implantation inside the body.

4. Apparatus according to claim 1 , wherein said electrode is adapted for long term contact with bile fluids.

5. Apparatus according to claim 1 , comprising an electrical activity sensor for sensing electrical activity of said cell and wherein said power source electrifies said electrode at a frequency higher than a sensed depolarization frequency of said cell, thereby causing said cell to depolarize at the higher frequency.

6. Apparatus according to claim 1 , wherein said pulse is designed to extend a plateau duration of an action potential of said cell, thereby allowing more calcium inflow into the cell.

7. Apparatus according to claim 1 , wherein said pulse is designed to reduce an action potential frequency of said cell, while not reducing insulin secretion from said cell.

8. Apparatus according to claim 1 , wherein said pulse is designed to extend a duration of a burst activity of said cell.

9. Apparatus according to claim 1 , wherein said pulse has an amplitude sufficient to recruit non-participating insulin secreting cells of said group of cells.

10. Apparatus according to claim 1 , comprising at least a second electrode adjacent for electrifying a second cell or group of insulin secreting cells, wherein said controller electrifies said second electrode with a second pulse different from said first electrode.

11. Apparatus according to claim 10 , wherein said second pulse is designed to suppress insulin secretion.

12. Apparatus according to claim 11 , wherein said controller is programmed to electrify said second electrode at a later time to forcefully secrete said insulin whose secretion is suppressed earlier.

13. Apparatus according to claim 11 , wherein said second pulse is designed to hyper-polarize said second cells.

14. Apparatus according to claim 1 , wherein said controller electrifies said at least one electrode with a pacing pulse having a sufficient amplitude to force a significant portion of said cells to depolarize, thus aligning the cells' action potentials with respect to the non-excitatory pulse electrification.

15. Apparatus according to claim 1 , wherein said controller synchronizes the electrification of said electrode to a burst activity of said cell.

16. Apparatus according to claim 1 , wherein said controller synchronizes the electrification of said electrode to an individual action potential of said cell.

17. Apparatus according to claim 1 , wherein said controller does not synchronize the electrification of said electrode to electrical activity of said cell.

18. Apparatus according to claim 1 , wherein said controller does not apply said pulse at every action potential of said cell.

19. Apparatus according to claim 1 , wherein said controller does not apply said pulse at every burst activity of said cell.

20. Apparatus according to claim 1 , wherein said pulse has a duration of less than a single action potential of said cell.

21. Apparatus according to claim 20 , wherein said pulse has a duration of less than a plateau duration of said cell.

22. Apparatus according to claim 1 , wherein said pulse has a duration of longer than a single action potential of said cell.

23. Apparatus according to claim 1 , wherein said pulse has a duration of longer than a burst activity duration of said cell.

24. Apparatus according to claim 1 , wherein said controller determines said electrification in response to a pharmaceutical treatment applied to the cell.

25. Apparatus according to claim 24 , wherein said pharmaceutical treatment comprises a pancreatic treatment.

26. Apparatus according to claim 24 , wherein said controller applies said pulse to counteract adverse effects of said pharmaceutical treatment.

27. Apparatus according to claim 24 , wherein said controller applies said pulse to synergistically interact with said pharmaceutical treatment.

28. Apparatus according to claim 24 , wherein said controller applies said pulse to counteract adverse effects of pacing stimulation of said cell.

29. Apparatus according to claim 1 , comprising an alert generator.

30. Apparatus according to claim 29 , wherein said controller activates said alert generator if said glucose level is below a threshold.

31. Apparatus according to claim 29 , wherein said controller activates said alert generator if said glucose level is above a threshold.

32. A method of controlling insulin secretion, comprising:

providing an electrode to at least a part of a pancreas;

applying a non-excitatory pulse to the at least part of a pancreas, which pulse increases secretion of insulin.

33. A method according to claim 32 , comprising applying an excitatory pulse in association with said non-excitatory pulse.

34. A method according to claim 32 , comprising applying a secretion reducing non-excitatory in association with said non-excitatory pulse.

35. A method according to claim 32 , comprising applying a plurality of pulses in a sequence designed to achieve a desired effect on said at least a part of a pancreas.

36. A pancreatic controller, comprising:

at least one electrode, adapted for electrifying an insulin producing cell or group of cells;

a power source for electrifying said at least one electrode with a waveform that does not initiate an action potential in said cell and has an effect of increasing insulin secretion; and

a controller which controls said power source to have a desired effect on a blood glucose level.

37. A controller according to claim 36 , wherein said power source electrifies said at least one electrode with an AC waveform.

38. A pancreatic controller, comprising:

a glucose sensor, adapted for sensing a level of glucose or insulin in a body serum;

at least one electrode, for electrifying an insulin producing cell or group of cells;

a power source for electrifying said at least one electrode with a pulse that extends an action duration of a burst activity of said cell; and

a controller which receives the sensed level and controls said power source to electrify said at least one electrode to have a desired effect on said level.

39. A method of controlling insulin secretion, comprising:

providing an electrode adapted to electrify at least a part of a pancreas having an electrical activity;

applying a non-excitatory AC pulse to the at least part of a pancreas, not synchronized to said electrical activity, which pulse modifies an insulin response of said pancreas to glucose levels.

40. A method of controlling body glucose levels, comprising:

providing an electrode adapted to electrify at least a part of a pancreas having an electrical activity;

applying a non-excitatory AC pulse to the at least part of a pancreas, not synchronized to said electrical activity, which pulse causes a reduction in glucose levels in a body containing said pancreas.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2019
From: SANDLEFORD PARK LIMITED
To: IMPULSE DYNAMICS N.V.
Reel/Frame 048989/0060 →
ASSIGNMENT OF TRADEMARK AND PATENT SECURITY AGREEMENT Recorded Apr 8, 2015
From: MEDINVEST CAPITAL S.A.R.L.; MORGAN STANLEY BANK INTERNATIONAL LIMITED
To: SANDLEFORD PARK LIMITED, AS SECURITY AGENT
Reel/Frame 035387/0041 →
SECURITY AGREEMENT Recorded Aug 3, 2009
From: MOTORIKA LIMITED
To: MORGAN STANLEY BANK INTERNATIONAL LIMITED; MEDINVEST CAPITAL S.A R.L.
Reel/Frame 023032/0774 →
SECURITY AGREEMENT Recorded Mar 26, 2009
From: METACURE LIMITED
To: MEDINVEST CAPITAL S.A R.L.; MORGAN STANLEY BANK INTERNATIONAL LIMITED
Reel/Frame 022449/0339 →
CHANGE OF NAME Recorded Feb 20, 2009
From: METACURE N.V.
To: METACURE LIMITED
Reel/Frame 022288/0350 →